Drug Profile
Somatropin biosimilar - Reliance Life Sciences
Alternative Names: r-hGH - Reliance Life Sciences; R-TPR-007; SomatoRelLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Reliance Life Sciences
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Somatotropin deficiency
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in Somatotropin-deficiency(In children) in India (SC)